Ion Beam Applications SA
XBRU:IBAB

Watchlist Manager
Ion Beam Applications SA Logo
Ion Beam Applications SA
XBRU:IBAB
Watchlist
Price: 13.74 EUR 4.09% Market Closed
Market Cap: 401.1m EUR
Have any thoughts about
Ion Beam Applications SA?
Write Note

Ion Beam Applications SA
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ion Beam Applications SA
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Ion Beam Applications SA
XBRU:IBAB
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biocartis Group NV
XBRU:BCART
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ion Beam Applications SA
Glance View

Market Cap
401m EUR
Industry
Health Care

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

IBAB Intrinsic Value
27.06 EUR
Undervaluation 49%
Intrinsic Value
Price

See Also

Back to Top